600195.SS
600195.SS
CNE000000Y03
CHINA ANIMAL HUSBANDRY INDUSTRY
Loading chart...

Company Profile

China Animal Husbandry Industry Co., Ltd., together with its subsidiaries, engages in research, development, production, sales, and technical services of animal health and nutrition products in China and internationally. It operates through four segments: Animal Disease Epidemic Prevention; Animal disease treatment; Animal Nutrition; and Others. The company offers veterinary biological products, such as poultry, livestock, and pet vaccines; biological products, including pathogenic avian influenza vaccines; veterinary chemical products which includes tylosin, tivamisins, florfenicol raw materials, mulex, fluoxetine, sulfachlorpyridazine sodium, and pet disinfectants; feed and feed additive products consist of compound vitamins and compound premixes under the Hualuo brand; trade of feed raw materials; and feed additives, such as corn and corn by-products, soybean and fish meal, and lysine. It also provides veterinary vaccines and drug products; and animal nutrition products. China Animal Husbandry Industry Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.

Related stocks

002737.SZ
002737.SZ • China
SFPM
11.53 CNY
1.01B USD 1Y -24.8%
000650.SZ
000650.SZ • China
RENHE PHARMACY CO LTD
5.29 CNY
1.11B USD 1Y -12.9%
300702.SZ
300702.SZ • China
TIANYU PHARMA
22.18 CNY
1.15B USD 1Y -13.6%
301263.SZ
301263.SZ • China
TEK
19.14 CNY
1.22B USD 1Y -31.8%
002275.SZ
002275.SZ • China
GLSJ
12.35 CNY
1.09B USD 1Y -16%
600557.SS
600557.SS • China
JIANGSU KANION PHARMACEUTICAL C
12.4 CNY
1.05B USD 1Y -18.4%
600129.SS
600129.SS • China
CHONGQING TAIJI IND
13.97 CNY
1.15B USD 1Y -36.3%
002349.SZ
002349.SZ • China
JINGHUA PHARM
9.24 CNY
1.15B USD 1Y +28.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
32.9% p.a.
Max Drawdown (5Y)
-65.0%
Sharpe Ratio (5Y)
-0.39
Beta Factor
0.28
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 48.1 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (32.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -72.8% in the extended horizon.
ende